Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Al-Sayed · SciRah

Researcher profile · Semantic Scholar

A. Al-Sayed

Share profile

A. Al-Sayed — researcher profile on SciRah

h-index: 5
Works: 14
Citations: 143

Most-cited papers

Interleukin-8 Activates Breast Cancer-Associated Adipocytes and Promotes Their Angiogenesis- and Tumorigenesis-Promoting Effects
Huda H. Al-Khalaf, Bothaina Al-Harbi, A. Al-Sayed, M. Arafah +4 more
2018Molecular and Cellular Biology49 citations Open access
Semantic Scholar
Defective gammadelta T-cell function and granzyme B gene polymorphism in a cohort of newly diagnosed breast cancer patients.
A. Gaafar, M. Aljurf, Abdullah Al-Sulaiman, A. Iqniebi +9 more
2009Experimental Hematology46 citations Open access
Semantic Scholar
Weekly Paclitaxel given concurrently with Durvalumab has a favorable safety profile in triple-negative metastatic breast cancer
H. Ghebeh, A. Al-Sayed, Riham Eiada, L. Cabangon +4 more
2021Scientific Reports21 citations Open access
Semantic Scholar
Obesity and p16INK4A Downregulation Activate Breast Adipocytes and Promote Their Protumorigenicity
Huda H. Al-Khalaf, Mrad Amir, F. Al-Mohanna, A. Tulbah +2 more
2017Molecular and Cellular Biology15 citations Open access
Semantic Scholar
Adding high-dose tamoxifen to CHOP does not influence response or survival in aggressive non-Hodgkin's lymphoma: an interim analysis of a randomized phase III trial
Adnan A. Ezzat, E. Ibrahim, Robert K. Stuart, D. Ajarim +5 more
2000Medical Oncology12 citations
Semantic Scholar
Abstract P059: An increase in eosinophils is associate with response to chemo-immunotherapy in metastatic triple negative breast cancer
H. Ghebeh, M. Elshenawy, A. Al-Sayed, T. Al-Tweigeri
2022Combinatorial Studies to Overcome Resistance to Immunotherapy0 citations
Semantic Scholar
Abstract P070: The safety and efficacy of Durvalumab and Paclitaxel combination in metastatic triple-negative breast cancer: An open-label phase I/II trial with 2-years follow-up
H. Ghebeh, A. Al-Sayed, Kauser Suleman, Riham Eiada +2 more
2022Other Topics0 citations
Semantic Scholar
Obesity and p 16 INK 4 A down-regulation activate breast adipocytes 1 and promote their pro-tumorigenicity 2 3 Running title : Obesity activates breast adipocytes
Huda H. Al-Khalaf, Mrad Amir, F. Al-Mohanna, A. Tulbah +2 more
20170 citations
Semantic Scholar
Abstract P1-11-08: A Multicenter Prospective Phase II Trial of Neo-Adjuvant (FEC 100)/Cisplatin-Docetaxel with or without Trastuzumab in Locally Advanced Breast Cancer. Gulf Oncology Research Group (G0RG-001)
T. Al-Tweigeri, A. Al-Sayed, M. Ibrahim, Wm Ashaur +6 more
20100 citations
Semantic Scholar
Prospective phase II study of neo-adjuvant doxorubicin followed by cisplatin /docetaxel in locally advanced breast cancer--5 years of follow up
D. Ajarim, M. Rahal, A. Al-Sayed, M. Al-Shabana +5 more
20070 citations
Semantic Scholar
Defective γδ T-Cell Function and Granzyme B Gene Polymorphism in Newly Diagnosed Breast Care Patients. Expansion with Zoledronic Acid Partially Compensates for This Deficiency.
A. Gaafar, Abdullah Al-Sulaiman, A. Iqniebi, A. Al-Sayed +7 more
20060 citations
Semantic Scholar
Prospective phase II study of: neo-adjuvant doxorubicin followed sequentially by cisplatin/docetaxel in locally advanced breast cancer
T. Al-Tweigeri, D. Ajarim, A. Al-Sayed, A. Tulba +4 more
20060 citations
Semantic Scholar
P95 Neoadjuvant Doxorubicin followed sequentially by Cisplatin-Docetaxel in locally advanced breast cancer
A. Ezzat, M. Rahal, D. Ajarim, A. Al-Sayed +4 more
20050 citations
Semantic Scholar
Salvage chemotherapy for Hodgkin's disease — A seven-drug containing regimen with and without stem cell transplant
M. Rahal, S. Bazarbashi, A. El-Weshi, M. Raja +6 more
19990 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Tulbah×7
Invite
A. Tulbah — researcher profile on SciRah
D. Ajarim×7
Invite
D. Ajarim — researcher profile on SciRah
T. Al-Tweigeri×7
Invite
T. Al-Tweigeri — researcher profile on SciRah
A. Ezzat×4
Invite
A. Ezzat — researcher profile on SciRah

Huda H. Al-Khalaf

×3

Invite

Huda H. Al-Khalaf — researcher profile on SciRah

F. Al-Mohanna×3

Invite

F. Al-Mohanna — researcher profile on SciRah

A. Aboussekhra×3

Invite

A. Aboussekhra — researcher profile on SciRah

Invite

H. Ghebeh — researcher profile on SciRah

Invite

M. Rahal — researcher profile on SciRah

M. Al-Shabana×3

Invite

M. Al-Shabana — researcher profile on SciRah

Invite

O. Al-Malik — researcher profile on SciRah

Invite

A. Gaafar — researcher profile on SciRah